Largest pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceutical companies ranked by total assets, at ZAR 2.6B, followed by Erasca (ZAR 6.8B) and Definium Therapeutics (ZAR 7.6B). Figures as of 18 Nov 2026, 16:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsZAR 2.6B
- Median
- ZAR 60.8B
- Combined market value
- ZAR 87.75T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | ZAR 2.6B | ZAR 90.3B | ZAR 2,140.29 | 1.25% down | 233% up | ||
| 2 | ErascaERAS · Health Care | ZAR 6.8B | ZAR 79.4B | ZAR 226.17 | 5.62% down | 403% up | ||
| 3 | Definium TherapeuticsDFTX · Health Care | ZAR 7.6B | ZAR 67.5B | ZAR 493.05 | 2.72% down | 169% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 8.3B | ZAR 140B | ZAR 2,019.62 | 0.39% up | 13% up | ||
| 5 | Oruka TherapeuticsORKA · Health Care | ZAR 8.4B | ZAR 112.9B | ZAR 1,664.59 | 0.18% up | 241% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | ZAR 9.2B | ZAR 84.3B | ZAR 1,496.13 | 0.29% down | 113% up | ||
| 7 | Edgewise TherapeuticsEWTX · Health Care | ZAR 9.5B | ZAR 77.8B | ZAR 710.76 | 2.00% down | 88% up | ||
| 8 | Travere TherapeuticsTVTX · Health Care | ZAR 10.4B | ZAR 83.3B | ZAR 867.83 | 1.56% down | 44% up | ||
| 9 | ABIVAXABVX · Health Care | ZAR 11.2B | ZAR 126.3B | ZAR 1,442.39 | 1.84% up | 27% down | ||
| 10 | Protagonist TherapeuticsPTGX · Health Care | ZAR 11.5B | ZAR 141.2B | ZAR 2,163.50 | 0.59% up | 46% up | ||
| 11 | Axsome TherapeuticsAXSM · Health Care | ZAR 11.9B | ZAR 121.5B | ZAR 2,310.65 | 1.48% down | 7% down | ||
| 12 | Summit TherapeuticsSMMT · Health Care | ZAR 13B | ZAR 146.4B | ZAR 183.04 | 0.56% down | 36% down | ||
| 13 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 13.2B | ZAR 130.1B | ZAR 1,655.88 | 0.92% up | 126% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | ZAR 13.4B | ZAR 156.3B | ZAR 1,645.78 | 1.69% up | 286% up | ||
| 15 | Belite BioBLTE · Health Care | ZAR 13.5B | ZAR 110.8B | ZAR 2,727.96 | 0.26% up | 31% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | ZAR 14.4B | ZAR 128.5B | ZAR 1,173.96 | 2.88% down | 8% down | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 14.5B | ZAR 103B | ZAR 1,577.64 | 0.54% down | 31% up | ||
| 18 | BridgeBio PharmaBBIO · Health Care | ZAR 16.1B | ZAR 260.9B | ZAR 1,339.57 | 1.11% up | 17% up | ||
| 19 | Cogent BiosciencesCOGT · Health Care | ZAR 16.2B | ZAR 84.8B | ZAR 487.44 | 1.45% up | 20% down | ||
| 20 | Praxis Precision MedicinesPRAX · Health Care | ZAR 16.2B | ZAR 147.3B | ZAR 5,268.41 | 0.11% up | 61% up | ||
| 21 | TG TherapeuticsTGTX · Health Care | ZAR 18.3B | ZAR 170.2B | ZAR 1,126.17 | 4.10% up | 107% up | ||
| 22 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 21.7B | ZAR 162.5B | ZAR 6,994.93 | 3.91% down | 24% down | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 23.9B | ZAR 104.9B | ZAR 742.16 | 0.07% up | 10% up | ||
| 24 | CytokineticsCYTK · Health Care | ZAR 24.6B | ZAR 123.2B | ZAR 884.05 | 0.78% down | 20% down | ||
| 25 | Ascendis PharmaASND · Health Care | ZAR 24.9B | ZAR 306.7B | ZAR 4,676.34 | 0.04% down | 28% up | ||
| 26 | Ligand PharmaceuticalsLGND · Health Care | ZAR 26.9B | ZAR 103.6B | ZAR 5,178.01 | 2.16% up | 43% up | ||
| 27 | Legend BiotechLEGN · Health Care | ZAR 29.9B | ZAR 54.3B | ZAR 279.99 | 0.74% up | 42% down | ||
| 28 | InsmedINSM · Health Care | ZAR 39.1B | ZAR 455.3B | ZAR 2,075.26 | 1.28% down | 40% down | ||
| 29 | AlkermesALKS · Health Care | ZAR 42.9B | ZAR 135.3B | ZAR 805.12 | 2.68% up | 58% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | ZAR 50B | ZAR 87B | ZAR 1,041.12 | 0.02% down | 20% down | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | ZAR 60.8B | ZAR 78.8B | ZAR 472.86 | 1.67% up | 64% down | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 63.5B | ZAR 129.6B | ZAR 371.85 | 2.06% up | 83% up | ||
| 33 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 85.7B | ZAR 350.3B | ZAR 2,615.57 | 3.12% down | 66% down | ||
| 34 | Roivant SciencesROIV · Health Care | ZAR 98.5B | ZAR 480.9B | ZAR 663.66 | 0.62% down | 90% up | ||
| 35 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 106.3B | ZAR 215.5B | ZAR 258.51 | 1.32% up | 5% up | ||
| 36 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 131B | ZAR 201.5B | ZAR 1,040.09 | 3.04% up | 11% up | ||
| 37 | United TherapeuticsUTHR · Health Care | ZAR 135.9B | ZAR 425.1B | ZAR 9,982.18 | 0.94% down | 23% up | ||
| 38 | BeOne MedicinesONC · Health Care | ZAR 141.3B | ZAR 794.3B | ZAR 6,953.35 | 2.47% down | 17% up | ||
| 39 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 201.1B | ZAR 270.3B | ZAR 4,211.50 | 1.42% up | 37% up | ||
| 40 | GenmabGMAB · Health Care | ZAR 222.1B | ZAR 544.6B | ZAR 883.27 | 1.46% down | 70% up | ||
| 41 | Elanco Animal HealthELAN · Health Care | ZAR 230.4B | ZAR 228.2B | ZAR 456.47 | 2.36% up | 20% up | ||
| 42 | ZoetisZTS · Health Care | ZAR 266.8B | ZAR 588.6B | ZAR 1,448.51 | 0.58% up | 29% down | ||
| 43 | Royalty PharmaRPRX · Health Care | ZAR 338.5B | ZAR 683B | ZAR 1,187.93 | 0.26% up | 78% up | ||
| 44 | GrifolsGRFS · Health Care | ZAR 377.3B | ZAR 100B | ZAR 146.90 | 1.33% down | 1% up | ||
| 45 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 442.4B | ZAR 2.34T | ZAR 9,234.16 | 0.20% up | 27% up | ||
| 46 | ViatrisVTRS · Health Care | ZAR 641.6B | ZAR 406.7B | ZAR 354.78 | 0.56% up | 96% up | ||
| 47 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 699.7B | ZAR 1.71T | ZAR 16,498.46 | 0.15% down | 36% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 703B | ZAR 850.7B | ZAR 729.04 | 0.84% down | 74% up | ||
| 49 | Novo NordiskNVO · Health Care | ZAR 1.39T | ZAR 3.01T | ZAR 682.12 | 2.85% down | 17% down | ||
| 50 | GSKGSK · Health Care | ZAR 1.4T | ZAR 1.69T | ZAR 841.70 | 0.91% down | 6% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | ZAR 1.5T | ZAR 3.14T | ZAR 1,810.36 | 0.22% up | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | ZAR 1.55T | ZAR 2.12T | ZAR 1,038.71 | 1.86% down | 34% up | ||
| 53 | Takeda PharmaceuticalTAK · Health Care | ZAR 1.68T | ZAR 1.18T | ZAR 368.75 | 1.22% down | 54% up | ||
| 54 | NovartisNVS · Health Care | ZAR 1.91T | ZAR 5.08T | ZAR 2,689.84 | 2.02% down | 25% up | ||
| 55 | Eli LillyLLY · Health Care | ZAR 1.94T | ZAR 21.31T | ZAR 23,921.24 | 2.04% down | 35% up | ||
| 56 | AstraZenecaAZN · Health Care | ZAR 1.97T | ZAR 4.8T | ZAR 3,093.18 | 1.63% down | 2% up | ||
| 57 | AbbVieABBV · Health Care | ZAR 2.31T | ZAR 8.82T | ZAR 4,988.07 | 1.26% down | 26% up | ||
| 58 | Merck & CoMRK · Health Care | ZAR 2.36T | ZAR 5.94T | ZAR 2,408.99 | 2.60% down | 51% up | ||
| 59 | SanofiSNY · Health Care | ZAR 2.43T | ZAR 1.96T | ZAR 816.25 | 0.45% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | ZAR 3.44T | ZAR 11.45T | ZAR 4,757.25 | 1.05% down | 38% up | ||
| 61 | PfizerPFE · Health Care | ZAR 3.59T | ZAR 2.77T | ZAR 486.23 | 1.00% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2514 ZAR).
Questions and answers
Which pharmaceutical companies have the lowest total assets?
Veradermics (ZAR 2.6B), Erasca (ZAR 6.8B) and Definium Therapeutics (ZAR 7.6B) have the lowest total assets of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 16:47 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total assets have a combined market value of ZAR 87.75T as of 18 Nov 2026, 16:47 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.